Advertisement
Regular Article| Volume 112, ISSUE 3, P151-158, 2003

The nontoxic mushroom Auricularia auricula contains a polysaccharide with anticoagulant activity mediated by antithrombin

  • Seon-Joo Yoon
    Affiliations
    Laboratório de Tecido Conjuntivo, Hospital Universitário Clementino Fraga Filho, and Departamento de Bioquı́mica Médica, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Caixa Postal 68041, Rio de Janeiro, RJ 21941-590, Brazil

    Department of Biotechnology and Bioproducts Research Center, Yonsei University, Seoul 120-749, South Korea

    Central Research Laboratories, Taiyo Kagaku Co., Ltd., Yokkaichi, Mie 510, Japan
    Search for articles by this author
  • Myeong-Ae Yu
    Affiliations
    Department of Biotechnology and Bioproducts Research Center, Yonsei University, Seoul 120-749, South Korea
    Search for articles by this author
  • Yu-Ryang Pyun
    Affiliations
    Department of Biotechnology and Bioproducts Research Center, Yonsei University, Seoul 120-749, South Korea
    Search for articles by this author
  • Jae-Kwan Hwang
    Affiliations
    Department of Biotechnology and Bioproducts Research Center, Yonsei University, Seoul 120-749, South Korea
    Search for articles by this author
  • Djong-Chi Chu
    Affiliations
    Central Research Laboratories, Taiyo Kagaku Co., Ltd., Yokkaichi, Mie 510, Japan
    Search for articles by this author
  • Lekh Raj Juneja
    Affiliations
    Central Research Laboratories, Taiyo Kagaku Co., Ltd., Yokkaichi, Mie 510, Japan
    Search for articles by this author
  • Paulo A.S. Mourão
    Correspondence
    Corresponding author. Departamento de Bioquı́mica Médica, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Caixa Postal 68041, Rio de Janeiro, RJ 21941-590, Brazil. Tel./fax: +55-21-2562-2090.
    Affiliations
    Laboratório de Tecido Conjuntivo, Hospital Universitário Clementino Fraga Filho, and Departamento de Bioquı́mica Médica, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Caixa Postal 68041, Rio de Janeiro, RJ 21941-590, Brazil
    Search for articles by this author

      Abstract

      An acidic polysaccharide with anticoagulant activity was isolated from the edible mushroom Auricularia auricula using water, alkali or acid extracts. The alkali extract showed the highest anticoagulant activity and was thereby further purified using gel filtration chromatography. Specific anticoagulant activity of the purified polysaccharide was 2 IU/mg and its average mass was ∼160 kDa. The polysaccharide from this species of mushroom contains mainly mannose, glucose, glucuronic acid and xylose but no sulfate esters. Its anticoagulant activity was due to catalysis of thrombin inhibition by antithrombin but not by heparin cofactor II. Inhibition of Factor Xa by antithrombin was not catalyzed by the polysaccharide. The glucuronic acid residues were essential for the anticoagulant action of the mushroom polysaccharide since the activity disappeared after reduction of its carboxyl groups. In ex vivo tests using rats orally fed with the polysaccharide, we observed an inhibitory effect on platelet aggregation as observed with aspirin, a well-known antiplatelet agent. The polysaccharides from these mushrooms may constitute a new source of compounds with action on coagulation, platelet aggregation and, perhaps, on thrombosis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Thrombosis Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Epstein F.H.
        Vascular-bed: specific hemostasis and hypercoagulable states.
        New Engl. J. Med. 1999; 340: 1555-1564
        • Kenneth G.M.
        Thrombosis: theoretical considerations.
        Am. J. Clin. Nutr. 1997; 65: 1657-1664
        • Nader H.B.
        • Dietrich C.P.
        Natural occurrence and possible biological role of heparin.
        in: Lane D.A. Lindahl U. Heparin: chemical and biological properties—clinical application. Auckland, London1989: 81
        • Jaques L.B.
        Heparin: an old drug with a new paradigm.
        Science. 1979; 206: 528-533
        • McGinnis D.M.
        • Outschoorn A.S.
        Problems of component activities of heparin.
        Pharmacop. Forum. 1991; 5: 2438-2441
        • Merton R.E.
        • Thomas D.P.
        Experimental studies on the relative efficacy of dermatan sulphate and heparin as antithrombotic agents.
        Thromb. Haemost. 1987; 8: 839-842
        • Minix R.
        • Doctor V.M.
        Interaction of fucoidan with proteases and inhibitors of coagulation and fibrinolysis.
        Thromb. Res. 1997; 87: 419-429
        • Nilsson M.
        • Rothman U.
        • Stenberb P.
        • Frohm B.
        • Persson H.A.
        A novel semisynthetic sulphated polysaccharide with potent antithrombin activity.
        Br. J. Haematol. 1982; 50: 335-343
        • Nishino T.
        • Aizu Y.
        • Nagumo T.
        The influence of sulfate content and molecular weight of a fucan sulfate from brown seaweek Ecklonia kurome on its antithrombin activity.
        Thromb. Res. 1991; 64: 723-731
        • Pereira M.
        • Mulloy B.
        • Mourão P.A.S.
        Structure and anticoagulant activity of sulfated fucans.
        J. Biol. Chem. 1999; 274: 7656-7667
        • Mauray S.
        • Sternberg C.
        • Theveniaux J.
        • Millet J.
        • Tapon-Bretaudiere J.
        • Fisher A.M.
        Venous antithrombotic and anticoagulant activities of a fucoidan fraction.
        Thromb. Haemost. 1995; 74: 1280-1285
        • Yoon S.J.
        • Pereira M.S.
        • Pavão M.S.G.
        • Hwang J.K.
        • Pyun Y.R.
        • Mourão P.A.S.
        The medicinal plant Porana volubilis contains polysaccharides with anticoagulant activity mediated by heparin cofactor II.
        Thromb. Res. 2002; 106: 51-58
        • Lee S.A.
        • Jung K.S.
        • Shim M.J.
        • Choi O.C.
        • Kim P.K.
        The study on anticancer component of Korea Basidiomycetes (II), Schizophyllum and Auricularia auricula-judae-judae.
        Korean Soc. Mycol. 1981; 9: 25-32
        • Ham S.S.
        • Kim D.H.
        • Choi K.P.
        • Lee D.S.
        Antigenotoxic effects of methyl alcohol extracts from Auricularia auricula and Gyrophora esculenta.
        J. Korean Soc. Food Sci. Nutr. 1997; 26: 57-62
        • Chang J.S.
        • Kim H.J.
        • Bae J.T.
        • Park S.H.
        • Kim S.E.
        • Kim O.M.
        • et al.
        Inhibition effects of Auricularia auricula-judae-judae methanol extract on lipid peroxidation and liver damage in benzo(α)pyrene-treated mice.
        J. Korean Soc. Food Sci. Nutr. 1998; 27: 712-717
        • Ham S.S.
        • Kim D.S.
        • Lee D.S.
        Antimutagenic effect of methyl alcohol extracts from Auricularia auricula and Gyrophora esculenta.
        Korean J. Food Sci. Technol. 1997; 29: 1281-1287
        • Kim S.S.
        • Kim Y.P.
        Kim S.S. Kim Y.P. Korean mushrooms. Yu-Pung Co., Ltd, Seoul, Korea1995: 321
        • Dubois M.
        • Gilles K.A.
        • Hamilton J.K.
        • Rebers P.A.
        • Smith F.
        Colorimetric method for determination of sugars and related substances.
        Anal. Chem. 1956; 175: 595-603
        • Dische Z.
        A new specific color reaction of hexuronic acid.
        J. Biol. Chem. 1947; 167: 189-198
        • Blakeney A.B.
        • Harris P.J.
        • Henry R.J.
        • Stone B.A.
        A simple and rapid preparation of alditol acetates for monosaccharide analysis.
        Carbohydr. Res. 1983; 113: 291-299
        • Saito A.
        • Yamagata T.
        • Suzuki S.
        Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfate.
        J. Biol. Chem. 1968; 243: 1536-1542
        • Gerhard A.
        • Ruiter D.
        • Brian R.
        Carrageenan biotechnology.
        Trends Food Sci. Technol. 1997; 8: 389-395
        • Rabin S.
        • Stillian J.
        • Barreto V.
        • Friedman K.
        • Toofan M.
        New membrane-based eletrolytic suppressor device for suppressed conductivity detection in ion chromatography.
        J. Chromatogr. 1993; 640: 97-109
        • Anderson L.O.
        • Barrowcliffe T.W.
        • Holmer E.
        • Johnson E.A.
        • Simes G.E.C.
        Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin-3 and by gel-filtration.
        Thromb. Res. 1976; 9: 575-580
        • National Research Council
        Guide for the care and use of laboratory animals: Animal environment, housing and management.
        in: Institute of Laboratory Animal Resource, Commission on Life Sciences. National Academy Press, Washington, DC1985: 85-123
        • Pavão M.S.G.
        • Mourão P.A.S.
        • Mulloy B.
        • Tollefsen D.M.
        A unique dermatan sulfate-like glycosaminoglycan from ascidian: its structure and the effect of its unusual sulfation pattern on anticoagulant activity.
        J. Biol. Chem. 1995; 270: 31017-31036
        • Alban S.
        • Franz G.
        Anticoagulant activity of curdlan sulfates in dependence on their molecular weight.
        Pure Appl. Chem. 1994; 66: 2403-2406
        • Pereira M.S.
        • Melo F.R.
        • Mourão P.A.S.
        Is there a correlation between structure and anticoagulant activity of sulfated galactans and sulfated fucans?.
        Glycobiology. 2002; 12: 573-580
        • Pacheco R.G.
        • Vicente C.P.
        • Zancan P.
        • Mourão P.A.S.
        Different antithrombotic mechanisms among glycosaminoglycans revealed with a new fucosylated chondroitin sulfate from an echinoderm.
        Blood Coagul. 2000; 11: 563-573
        • Nishino T.
        • Nagumo T.
        Antithrombin activity of a fucan sulfate from the brown seaweed Ecklonia kurom.
        Thromb. Res. 1991; 62: 765-773
        • Pires L.
        • Gorin P.A.J.
        • Reicher F.
        • Sierakowski M.R.
        An active heparinoids obtained by sulfation of a galactomannan extracted from the endosperm of Senna macranthera seeds.
        Carbohydr. Polym. 2001; 46: 165-169
        • Coller B.S.
        GPIIb/IIIa antagonists: pathophysiologic and therapeutic insights from studies of c7E3 Fab.
        Thromb. Haemost. 1997; 78: 730-735
        • Schomig A.
        • Neumann F.J.
        • Kastrati A.
        A randomized comparision of antiplatelet and anticoagulant therapy after the placement of coronary artery stents.
        New Engl. J. Med. 1996; 334: 1084-1089
        • Weitz J.I.
        • Hirsh J.
        New anticoagulant strategies.
        J. Lab. Clin. Med. 1993; 122: 364-374
        • Bates S.M.
        • Weitz J.I.
        Prevention of activation of blood coagulation during acute coronary ischemic syndromes: beyond aspirin and heparin.
        Carbohydr. Res. 1999; 41: 418-432
        • Soslau G.
        • Class R.
        • Morgan D.A.
        • Foster C.
        • Lord S.T.
        • Marchese P.
        • et al.
        Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib.
        J. Biol. Chem. 2001; 276: 21173-21183
        • Rajtar G.
        • Marchi E.
        • de Gaetano G.
        • Cerletti C.
        Effects of glycosaminoglycans on platelet and leucocyte function: role of N-sulfation.
        Biochem. Pharmacol. 1993; 46: 958-960
        • Farias W.R.L.
        • Nazareth R.A.
        • Mourão P.A.S.
        Dual effects of sulfated d-galactans from the red algae Botryocladia occidentalis preventing thrombosis and inducing platelet aggregation.
        Thromb. Haemost. 2001; 86: 1540-1546